Events

Australian businesses have been incited to participate in the newly launched Medtronic APAC Innovation Challenge (MAIC).

Inventia Life Science's RASTRUM 3D cell culture platform has won the ANSTO Eureka Prize for Innovative Use of Technology at the 2021 Australian Museum Eureka Prizes. 

The fully subscribed capital raising was managed by Henslow and the company said it will use the funds to build its organisation and progress its technology development program.

Clinical stage immuno-oncology company Imugene (ASX:IMU) has announced that the City of Hope cancer research and treatment centre has dosed the first patient in the Phase 1 clinical trial of its oncolytic virotherapy candidate.

Telix Pharmaceuticals (ASX:TLX) has announced the first set of peer-reviewed results from the IPAX-1 Ph I/II study of TLX101 in combination with external beam radiation therapy in recurrent glioblastoma multiforme.

Food Standards Australia New Zealand is calling for feedback on its proposal to amend the definitions for gene technology and new breeding techniques, for clarity and to accommodate food produced by existing, emerging and future genetic technologies.

Dimerix is partnering with the NHMRC Clinical Trials Centre at the University of Sydney to expand a feasibility/phase 3 trial of its DMX-200 drug candidate to treat COVID-19 sufferers with respiratory complications.

PharmAust (ASX:PAA) has provided an update on its Phase 2b trial testing the anti-cancer activity of monepantel in pet dogs with B-cell lymphoma.

Microbio has moved into new laboratories at Brisbane’s Translational Research Institute (TRI) with the aim of eventually setting up domestic manufacturing capability.

Patrys (ASX:PAB) has announced data from its completed pre-clinical study that has demonstrated that its full-sized deoxymab antibody, PAT-DX3, can be used as a targeting agent for antibody-drug conjugates to deliver anti-cancer drugs to tumours.

A newly-proposed standardised IP Framework is a long-supported idea, but should be voluntary, recommended a joint submission by Research Australia, AusBiotech, Medicines Australia and MTAA to the Department of Education, Skills and Employment’s recent consultation.

Bright ideas are wanted as the Biosecurity Innovation Program opens its expressions of interest, and seeks innovative technologies and approaches to keep Australia disease and pest free.